These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11062900)

  • 21. Addition of insulin to oral therapy in type 2 diabetes.
    Dağdelen S
    N Engl J Med; 2008 Mar; 358(11):1197; author reply 1198. PubMed ID: 18337612
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M; Orsini-Federici M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and emerging therapies: an overview of incretin-based therapy in the management of type 2 diabetes.
    Pratley RE
    J Am Acad Nurse Pract; 2008 Nov; 20 Suppl 1():7-11. PubMed ID: 19402254
    [No Abstract]   [Full Text] [Related]  

  • 24. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].
    Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
    Ter Arkh; 2010; 82(8):34-41. PubMed ID: 20873243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus].
    Takamatsu J
    Nihon Rinsho; 1990 Dec; 48 Suppl():1031-7. PubMed ID: 2086864
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
    Westphal SA; Palumbo PJ
    Arch Intern Med; 2003 Aug 11-25; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modern approaches to pharmacotherapy of diabetes mellitus type II].
    Kovel'man IR; Tochilkin AI; Beliaeva NF; Gorodetskiĭ VK; Kniazhev VA; Tkachenko SB; Semenov LL; Semenova NV
    Vopr Med Khim; 2002; 48(4):337-52. PubMed ID: 12506608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The present and future of treatment with oral antidiabetic agents].
    Rybka J
    Cas Lek Cesk; 1998 Mar; 137(5):137-44. PubMed ID: 9588096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type II diabetes: insulin versus oral agents.
    Chalmers TC
    N Engl J Med; 1986 Nov; 315(19):1233-4. PubMed ID: 3531868
    [No Abstract]   [Full Text] [Related]  

  • 30. [Practical points in the use of insulin and oral hypoglycemic agents].
    Nakayama H
    Hokkaido Igaku Zasshi; 1989 Jul; 64(4):387-90. PubMed ID: 2684832
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
    Tanenberg RJ
    Curr Med Res Opin; 2004 Apr; 20(4):541-53. PubMed ID: 15119992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of diabetes mellitus with oral antidiabetics].
    Froesch ER
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1665-7. PubMed ID: 827809
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin therapy for type 2 diabetes.
    Pergallo-Dittko V
    Diabetes Self Manag; 2003; 20(5):17, 21, 23-4. PubMed ID: 14679948
    [No Abstract]   [Full Text] [Related]  

  • 36. Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapy.
    Buse JB
    Diabetes Care; 1999 Apr; 22 Suppl 3():C65-70. PubMed ID: 10189565
    [No Abstract]   [Full Text] [Related]  

  • 37. [Warning signals insulin resistance. Insulin resistance causes not only diabetes].
    MMW Fortschr Med; 2004 Jul; 146(29-30):49. PubMed ID: 15540564
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral hypoglycaemic agents in the treatment of immunogenic insulin resistance in NIDDM.
    Ramachandran A; Snehalatha C; Mohan V; Rao CA; Viswanathan M
    Diabete Metab; 1987 Apr; 13(2):140-1. PubMed ID: 3595969
    [No Abstract]   [Full Text] [Related]  

  • 39. [Oral hypoglycemic agents, present and future].
    Shimano H
    Nihon Yakurigaku Zasshi; 2006 Jul; 128(1):42-5. PubMed ID: 16948200
    [No Abstract]   [Full Text] [Related]  

  • 40. Exploring treatment strategies for type 2 diabetes.
    Bloomgarden ZT
    Diabetes Care; 2007 Oct; 30(10):2737-45. PubMed ID: 17901531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.